AfternsAfterns
Up or down this time?Nov 5 scheduled
0%0%

···

AM

Amylyx Pharmaceuticals Inc. (AMLX) earnings date & stock reaction

Amylyx Pharmaceuticals Inc. · Healthcare

Amylyx Pharmaceuticals Inc. earnings date & time

Next earningsThu, November 5 around 8:00 AM ET, before the openscheduled

Schedule

Korea time (KST)
Thu, November 5
Reporting pattern
12 of last 12 before open
Typical move
±8.7% · 12-report avg

What the market expects

Consensus EPS

$-0.37Coming in above this counts as a beat

Year-ago quarter
$-0.37→+0.0%
Full earnings calendarFrom an earnings calendar

Price after the latest report

Reported August 6, 2026how the stock moved around it
Next-day move
+10.7%
After 5 days
+6.9%
Price around earnings
Around this report
Overlapped jobs releaseA major data release (CPI, jobs) came out around this report. On those days the whole market moves, so the reaction may be mixed with the data.Ran up +8% into earningsIn the 3 trading days before this report, the stock moved more than usual. A pre-earnings run-up can mean expectations were already priced in, a drop can mean bad news was priced in early. Read the post-earnings reaction with that in mind.

Amylyx Pharmaceuticals Inc. (AMLX) rose the day after earnings in 4 of its last 12 reports (33%), moving ±8.7% on average. It has fallen despite beating the consensus estimate 4 times.

Up next day
4/12
33%
Fell despite growth
6/12
Good earnings ignored
Price when beating
-4.7%
avg over 5 beats
Price when missing
-0.9%
avg over 7 misses
Avg earnings move
±8.7%
typical swing on earnings
Biggest single move
-31.9%
'23.11 · largest reaction
🔑What actually moves this stock?
What really matters here
Key product sales and the company's outlook
In finance terms: Product sales · guidance
Growth · revenue (YoY by quarter, latest right)
-100%
24-11(Sep qtr)
-101%
25-03(Dec qtr)
-100%
25-05(Mar qtr)
+100%
25-08(Jun qtr)
-100%
25-11(Sep qtr)
+100%
26-03(Dec qtr)
Spiked (M&A/one-off?) · It jumped to +100% last quarter, but before that it was slowing (-100% → -100%). This spike may be M&A/one-off.
What to watch next report

When results drop, skip the EPS number. Check if the growth above holds or accelerates, and whether guidance beats expectations.

The real bar for this stock

Beating estimates isn't enough. Here's where the real surprise started.

Beat consensus 5 of 11 times
Median beat +13.9%. 4 of those beats still fell the next day.

How this stock reacts to earnings

Traits seen across its recent earnings reactions

Tends to run up in the week before earnings
Rose beforehand 8 of last 12 · avg +3.7% · expectations build early
Even strong results barely move the stock
Up the next day 1 of 5 beats (20%)
Reaction is erratic and hard to predict
Avg -4.7% on a beat, -0.9% on a miss
vs Healthcare sector avg (155 peers)
This
-2.5%
Sector
+0.6%
Avg next-day reaction

Earnings number vs guidance: which drives it?

How often the beat/miss matched the actual price move

This stock reacts more to guidance & expectations than the reported number
Moved opposite to results 7 of last 12 times (58%)
4xBeat but fell
Even a beat sells off if guidance disappoints
3xMissed but rose
Even a miss rebounds if guidance reassures
Fell despite growth6/12

4/5 beats fell next day · watches Product sales · guidance

Next-day reaction
  • Jun 2026 report+10.7%
  • Mar 2026 report-5.3%
  • Dec 2025 report-7.8%
  • Sep 2025 report-5.9%
  • Jun 2025 report-4.3%
  • Mar 2025 report-6.0%

Earnings timeline · bars = next-day move, ▲▼ = beat/miss

Apr–Jun 2026 results
Reported 2026-08-06
Next-day move
+10.7%
After 5 days +6.9%
EPS consensus -$0.36 → -$0.39 ▼ -9.0% miss
Missed by -9.0% but stock +10.7%
Price around earnings
Around this report
Overlapped jobs releaseA major data release (CPI, jobs) came out around this report. On those days the whole market moves, so the reaction may be mixed with the data.Ran up +8% into earningsIn the 3 trading days before this report, the stock moved more than usual. A pre-earnings run-up can mean expectations were already priced in, a drop can mean bad news was priced in early. Read the post-earnings reaction with that in mind.

Earnings trend · last 12 quarters

EPS$-0.39YoY +15%
'23.11'26.8
Revenue—
'23.11'26.8

Earnings history and price reaction

Amylyx Pharmaceuticals Inc. across its last 12 earnings reports: EPS versus consensus, the move on the earnings day, and the cumulative move five trading days later.
Quarter endedReported (ET)vs market expectation (consensus)Earnings dayAfter 5 days
6/20262026-08-06-9.0%+10.7%+6.9%
3/20262026-05-07-8.7%-5.3%-9.2%
12/20252026-03-03+12.2%-7.8%-6.5%
9/20252025-11-06+13.9%-5.9%-6.9%
6/20252025-08-07-1.2%-4.3%+1.3%
3/20252025-05-08+16.0%-6.0%-10.7%

12 reports, quarters ending 9/2023 to 6/2026. The earnings-day move is the first trading day that reflects the report; the five-day figure is the cumulative move from that point.

Frequently asked questions

When is the next Amylyx Pharmaceuticals Inc. earnings date?

The next Amylyx Pharmaceuticals Inc. (AMLX) earnings report is expected Thu, November 5 around 8:00 AM ET, before the open. It comes from an earnings calendar and may not be a company-confirmed date; it updates automatically if it changes.

What is the consensus EPS forecast for Amylyx Pharmaceuticals Inc.'s next earnings?

Analysts expect EPS of about $-0.37 for Amylyx Pharmaceuticals Inc. (AMLX). Coming in above that counts as a beat, below it a miss — though a beat does not guarantee the stock rises.

Does Amylyx Pharmaceuticals Inc. (AMLX) stock usually go up after earnings?

Over the last 12 earnings reports, the stock rose on 4 of them (33%). The average move on earnings day was ±8.7%.

Does Amylyx Pharmaceuticals Inc. react more to the earnings numbers or to guidance?

In 7 of the last 12 reports (58%), the stock moved the opposite way from whether it beat or missed the forecast. A high share means guidance and expectations drive the move more than the reported numbers.

Can Amylyx Pharmaceuticals Inc. stock fall even when earnings are good?

Yes. In 6 of the last 12 reports, Amylyx Pharmaceuticals Inc. fell on the earnings day despite growing EPS. Expectations already priced in, or guidance, can matter more than the reported numbers.

Does Amylyx Pharmaceuticals Inc. stock keep moving after the earnings day?

Over the last 12 reports, the move continued in the same direction for the following five trading days 50% of the time. This tendency is known as post-earnings announcement drift.